Day: June 23, 2021

Lima, June 23, 2021 (GLOBE NEWSWIRE) — Credicorp Ltd. (NYSE: BAP) announces that the Board of Directors, in its session held on June 23rd, 2021, has appointed Gianfranco Ferrari as the new CEO of Credicorp, effective January 2022. Today, Mr. Ferrari is Deputy CEO and Head of Universal Banking, the main Line of Business at Credicorp. Gianfranco Ferrari will succeed Walter Bayly, who decided to retire at the end of 2021 after an extraordinary 28 year career at the Group, including the last three years as CEO of Credicorp and the previous 10 years as CEO of our main subsidiary, Banco de Credito del Peru (BCP). Gianfranco Ferrari, the right person to take the lead“Gianfranco is the right person to guide Credicorp in this new era” – said Luis Romero, Executive Chairman of the Board. “He will run Credicorp, not only because of his outstanding...

MONACO, June 23, 2021 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE:STNG) (“Scorpio Tankers,” or the “Company”) announced today that it has closed its previously announced private exchange offer (the “Exchange Offer”), pursuant to which certain holders of the Company’s 3.00% Convertible Senior Notes due 2022 (the “Existing Notes”) exchanged $19.4 million in aggregate principal amount of such Existing Notes for $19.4 million in aggregate principal amount of the Company’s 3.00% Convertible Senior Notes due 2025 (the “Exchange Notes”). In addition, the Company has closed separate, privately negotiated, agreements with certain investors for the sale (the “Sale”) of $42.4 million in aggregate principal amount of the new 3.00% Convertible Senior Notes due 2025 (the “Purchased Notes” at 102.25% of par, plus accrued interest from May 15,...

Study highlights the clinical performance of NIS4® technology in diagnosing at-risk NASH in patients with type 2 diabetes irrespective of age compared to other non-invasive tests New analyses show the potential of NIS4® technology to be a valuable clinical tool either alone or in sequential combination with other blood-based non-invasive tests in identifying at-risk NASH and advanced fibrosis in patients with and without type 2 diabetes   Key Opinion Leaders highlight the potential for non-invasive tests in the diagnosis of at-risk NASH on ADA TVLille, France; Cambridge, MA; June 23, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, today announced it will be making two poster presentations at two internationally-renown...

FORT LAUDERDALE, Fla., June 23, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced the appointment of Sonja Nelson, CPA to the Company’s Board of Directors and as Chair of the Audit Committee. Ms. Nelson brings more than 25 years of financial and operational leadership and expertise in biotechnology, diagnostics, and biopharmaceuticals markets, including playing an integral role in the successful merger between NantKwest, Inc. (Nasdaq: NK) and Immunity Bio, Inc. (Nasdaq: IBRX). “We are thrilled to welcome Sonja to our Board of Directors,” commented...

RALEIGH, N.C., June 23, 2021 (GLOBE NEWSWIRE) — Highwoods Properties, Inc. (NYSE:HIW) has sold Preserve VII, a 115,000 square foot single customer building in north Tampa, for $43.0 million. This property is 100% occupied and is projected to generate $2.0 million of annual cash net operating income, including the impact of $0.4 million of free rent, and $2.4 million of annual GAAP net operating income in 2021. The Company expects to record a non-FFO gain of approximately $22.8 million in the second quarter of 2021 in connection with this sale. Ted Klinck, President and Chief Executive Officer of Highwoods Properties, said, “This sale is the first closing in our plan to substantially fund our planned portfolio acquisition from PAC with proceeds from non-core asset sales. We are pleased with the execution of this sale and buyer interest...

HiFi Sequencing will be used on a cohort of rare disease cases with the aim to identify numerous variants, both small and structural, that are not readily detectable by short-read sequencing MENLO PARK, Calif., June 23, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read sequencing platforms, and Rady Children’s Institute for Genomic Medicine (RCIGM), a mission-driven, non-profit seeking to save lives and improve outcomes for patients, clinicians and families, shared today that they are collaborating on a study which aims to identify potential disease-causing genetic variants and increase the solve rates of rare diseases. The study is focused on long-read whole genome sequencing of rare disease cases for which previous short-read...

MONTREAL, June 23, 2021 (GLOBE NEWSWIRE) — Nouveau Monde Graphite Inc. (“Nouveau Monde” or the “Company”) (NYSE: NMG; TSXV: NOU) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 7,915,000 of its common shares (the “Common Shares”), which includes the partial exercise by the underwriters of their option to purchase additional Common Shares, at a price per share of US$7.50 (the “Offering Price”) for aggregate gross proceeds of US$59,362,500. Evercore ISI and BMO Capital Markets acted as joint book-running managers for the Offering. B. Riley Securities and Stifel GMP also acted as joint book-running managers. Roth Capital Partners acted as co-manager for the Offering. One of the Company’s current shareholders, Pallinghurst Graphite International Limited, through its subsidiary...

[NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR FOR DISSEMINATION IN THE UNITED STATES] FRANKLIN, Ind., June 23, 2021 (GLOBE NEWSWIRE) — IBC Advanced Alloys Corp. (“IBC” or the “Company”) (TSX-V: IB; OTCQB: IAALF) is pleased to announce that it has closed the Company’s previously announced non-brokered private placement (the “Offering”). Pursuant to the Offering, the Company issued 10,270,224 units of the Company (the “Units“) at a price of C$0.20 per Unit for gross proceeds to the Company of approximately C$2,054,000. Each Unit consists of one common share of IBC (each, a “Common Share“) and one common share purchase warrant (a “Warrant“). Each Warrant will entitle the holder to acquire one common share of the Company at a price of C$0.23 until June 23, 2023. All of the securities issued pursuant...